ProMIS Neurosciences Inc. (ON) Stock Performance

Open $9.05	Prev. Close $9.24	Circuit Range N/A
Day Range $9.05 - $9.16	Year Range $0.29 - $27.05	Volume 360
Average Traded $9.11

ProMIS Neurosciences Inc. (ON) Share Price Today

As of 9 October 2026, ProMIS Neurosciences Inc. (ON)'s share price is $9.16. The stock opened at $9.05, compared to its previous close of $9.24. During today's trading session, ProMIS Neurosciences Inc. (ON)'s share price traded between $9.05 and $9.16, with an average price of $9.11. Over the past 52 weeks, the stock has recorded a high of $27.05 and a low of $0.29. In terms of performance, ProMIS Neurosciences Inc. (ON)'s share price has declined by 16.80% over the last six months and is up 2091.39% on a year-on-year basis.

ProMIS Neurosciences Inc. (ON) Share Price Chart

$9.05$9.16

ProMIS Neurosciences Inc. (ON) Stock Fundamentals & Key Indicators

Market Cap $16.09M	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-4.71	Revenue (TTM) $0.00	Return On Equity (TTM) -85.48%
Profit Margin N/A	Debt to Equity 0.00	Quarterly Earnings Growth YoY -1.30%

ProMIS Neurosciences Inc. (ON) Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$11.58	-$10.67	-$8.24	-$11.73
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	7.86%	22.77%	-42.35%

ProMIS Neurosciences Inc. (ON) Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$18.06	-$13.21	$2.78	-$39.72
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	26.85%	121.04%	-1528.78%

About ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimers disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Compnies product candidates are PMN310, PMN267, and PMN442. Lead product candidate is PMN310, a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 is companies second lead product candidate targeting ALS.

ProMIS Neurosciences Inc. (ON) Historical Returns

Month	Open	Close	Change %
Oct 2026	$10.51	$9.16	-12.09%
Sep 2026	$13.38	$10.42	-25.89%
Aug 2026	$14.27	$14.06	+2.03%
Jul 2026	$13.47	$13.78	+2.91%
Jun 2026	$10.48	$13.39	+20.31%
May 2026	$11.01	$11.13	+1.09%
Apr 2026	$12.96	$11.01	-14.72%
Mar 2026	$21.21	$12.91	-45.18%
Feb 2026	$13.41	$23.55	+66.43%
Jan 2026	$7.04	$14.15	+102.43%
Dec 2025	$6.75	$6.99	+3.63%
Nov 2025	$0.41	$6.75	+1,513.64%

PMN Share Price FAQs

What is ProMIS Neurosciences Inc. (ON) share price today?

ProMIS Neurosciences Inc. (ON) share price today is $9.16 as on October 9, 2026 at 12:39 am IST.

What is the 52 week high and 52 week low of ProMIS Neurosciences Inc. (ON) stock?

The 52 week high of ProMIS Neurosciences Inc. (ON) stock is $27.05, while the 52 week low is $0.29 as of 9 Oct '26.

What is PMN's market capitalisation today?

PMN market capitalisation is $16.09M as of October 9, 2026, at 9:54 am IST.

What is PMN's net income for the last quarter?

PMN's net income for the last quarter is -11.73B USD.

What is the 5 year returns of PMN?

The 5 year returns of PMN is 50.91% as on 9 Oct '26.

What is the high & low stock price of PMN today?

PMN stock price hit a high of $9.16 and low of $9.05 as of 9 Oct '26.

Can I buy PMN shares in India?

Yes. You can buy PMN in India by opening an international trading account.